EC greenlights Acadia’s DAYBU for Rett Syndrome in Europe
Acadia Pharmaceuticals has secured EC approval for DAYBU (trofinetide) for the neurobehavioural symptoms of Rett syndrome in the EU.
Newsletters and Deep Dive digital magazine
Acadia Pharmaceuticals has secured EC approval for DAYBU (trofinetide) for the neurobehavioural symptoms of Rett syndrome in the EU.
Japan has approved GSK's antisense oligonucleoide Hibsago (bepirovirsen) as a functional cure in chronic hepatitis B virus infection in adult patients
Eli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription.
US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of FDA commissioner.
India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.
Editor's Picks
Newsletters and Deep Dive
digital magazine